|
1
|
Zalejska-Fiolka J, Birková A, Wielkoszyński T, Hubková B, Szlachta B, Fiolka R, Błaszczyk U, Kuzan A, Gamian A, Mareková M, Toborek M. Loss of Skeletal Muscle Mass and Intracellular Water as Undesired Outcomes of Weight Reduction in Obese Hyperglycemic Women: A Short-Term Longitudinal Study. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022; 19:1001. [PMID: 35055821 PMCID: PMC8775667 DOI: 10.3390/ijerph19021001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/23/2021] [Revised: 01/13/2022] [Accepted: 01/14/2022] [Indexed: 12/12/2022]
Abstract
The current study is focused on the influence of hyperglycemia on weight loss in obese premenopausal women. Specifically, the study evaluated the impact of a six-month individualized low-calorie diet combined with moderate exercise on weight reduction and glucose metabolism in obese women with normoglycemia compared to obese women with moderate hyperglycemia. The results indicated that patients with normoglycemia achieved a successful weight loss, which was connected to a decrease in adipose tissue and reflected by diminished content of visceral fat area (VFA) and percent body fat. In contrast, weight reduction in patients with hyperglycemia was connected not only to the loss of VFA but also to undesired decrease in skeletal muscle mass as well as intracellular and total body water. These unfavorable outcomes were observed despite normalization of glucose metabolism reflected by statistically significant lowering glucose, fructosamine, advanced glycation end-products, and HOMA-IR levels. Overall, the obtained results indicate the importance of the measurement of the carbohydrate profile in obese women and the need for an early introduction of weight reduction strategies before the development of hyperglycemia.
Collapse
Affiliation(s)
- Jolanta Zalejska-Fiolka
- Department of Biochemistry, Faculty of Medical Science in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland; (J.Z.-F.); (B.S.); (U.B.)
| | - Anna Birková
- Department of Clinical and Medical Biochemistry, Pavol Jozef Šafárik University, 040 11 Košice, Slovakia;
| | | | - Beáta Hubková
- Department of Clinical and Medical Biochemistry, Pavol Jozef Šafárik University, 040 11 Košice, Slovakia;
| | - Beata Szlachta
- Department of Biochemistry, Faculty of Medical Science in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland; (J.Z.-F.); (B.S.); (U.B.)
| | - Rafał Fiolka
- Doctoral School, Faculty of Medical Science in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland;
| | - Urszula Błaszczyk
- Department of Biochemistry, Faculty of Medical Science in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland; (J.Z.-F.); (B.S.); (U.B.)
| | - Aleksandra Kuzan
- Department of Medical Biochemistry, Wrocław Medical University, 50-367 Wrocław, Poland;
| | - Andrzej Gamian
- Institute of Immunology and Experimental Therapy, 53-114 Wrocław, Poland;
| | - Mária Mareková
- Department of Clinical and Medical Biochemistry, Pavol Jozef Šafárik University, 040 11 Košice, Slovakia;
| | - Michał Toborek
- Department of Biochemistry and Molecular Biology, University of Miami School of Medicine, Miami, FL 33136, USA;
| |
Collapse
|